From: Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis
Variables | SDF-1α expression (n (%)) | Total N | χ 2 | P | ||
---|---|---|---|---|---|---|
Negative | Low | High | ||||
Age at diagnosis (years) | ||||||
<60 | 14 (11.2) | 43 (34.4) | 68 (54.4) | 125 | 1.133 | 0.567 |
≥60 | 12 (15.6) | 28 (36.4) | 37 (48.0) | 77 | ||
Menopausal status | ||||||
Yes | 15 (10.6) | 53 (37.6) | 73 (51.8) | 141 | 2.604 | 0.272 |
No | 11 (18.0) | 18 (29.5) | 32 (52.5) | 61 | ||
Histologic subtype | ||||||
Endometrioid | 22 (11.9) | 66 (35.7) | 97 (52.4) | 185 | 1.616 | 0.446 |
Nonendometrioid | 4 (23.5) | 5 (29.4) | 8 (47.1) | 17 | ||
Histopathologic grade | ||||||
G1 | 14 (14.4) | 34 (35.1) | 49 (50.5) | 97 | 1.460 | 0.834 |
G2 | 7 (9.2) | 29 (38.2) | 40 (52.6) | 76 | ||
G3 | 4 (13.8) | 9 (31.0) | 16 (55.2) | 29 | ||
Myometrial invasion | ||||||
<1/2 | 16 (10.9) | 60 (40.8) | 71 (48.3) | 147 | 7.998 | 0.018* |
≥1/2 | 10 (18.2) | 11 (20.0) | 34 (61.8) | 55 | ||
FIGO stage | ||||||
I–II | 22 (13.2) | 63 (37.7) | 82 (49.1) | 167 | 3.456 | 0.172 |
III–IV | 4 (11.4) | 8 (22.9) | 23 (65.7) | 35 | ||
Lymph node metastasis | ||||||
Yes | 1 (6.3) | 2 (12.5) | 13 (81.2) | 16 | 6.530 | 0.038* |
No | 24 (12.9) | 70 (37.6) | 92 (49.5) | 186 |